Advertisement

Person › Details
Zhisheng (Chris) Chen (WuXi Biologics (2269.HK))
Chen, Zhisheng (Chris) (WuXi Pharmatech 201812 CEO of WuXi Biologics)
![]() |
Organisation | WuXi Biologics (2269.HK) |
Group | WuXi PharmaTech (Group) | |
![]() |
Product | contract manufacturing (biologicals) |
Product 2 | drug development services | |
Record changed: 2025-01-13 |
Advertisement

More documents for Zhisheng (Chris) Chen
- [1] Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried....
- [2] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top